Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07167953 · ClinicalTrials.gov registry record · NA
The Spiral MRI Study
A NA study, sponsored by University of Wisconsin, Madison.
- Not yet
- Registry status
- NA
- Development phase
- 131
- Enrollment target
NCT07167953: Clinical Trial NA study, sponsored by University of Wisconsin, Madison.
NCT07167953 is a NA study that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 131 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07167953, a NA study, has not yet begun recruiting, sponsored by University of Wisconsin, Madison.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 131 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to find out if new Magnetic Resonance Imaging (MRI) computer software will: * help make scans and exams faster * reduce artifacts * make MRI easier to understand * allow technicians to focus more on the participant and less on the scanner Participants will complete one brain MRI imaging session, lasting about 60 minutes.
Primary Outcome
Participants will be scanned using 2 versions (standard and spiral) of 6 sequences (12 scans total). For each sequence pair, scan time will be sped up. Image quality will be compared between the 2 versions.
Interventions
- DEVICE Brain MRI
- DEVICE Brain MRI - SOC and spiral
- DEVICE Brain MRI - spiral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2028-08 |
| Est. Completion | 2031-05 |
| Phase | NA |
What is known before NCT07167953 opens enrollment
NCT07167953 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 3 interventions - of which Brain MRI is the first listed.
NCT07167953 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07167953 about?
NCT07167953 is a clinical study titled "The Spiral MRI Study". The goal of this clinical trial is to find out if new Magnetic Resonance Imaging (MRI) computer software will: * help make scans and exams faster * reduce artifacts * make MRI easier to understand * allow technicians to focus more on the participant and less on the scanner Participants will comple...
What is the current status of trial NCT07167953?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 131 participants. The study started on 2028-08. Estimated completion is 2031-05.
What interventions are being tested in trial NCT07167953?
The interventions under investigation include: Brain MRI (DEVICE), Brain MRI - SOC and spiral (DEVICE), Brain MRI - spiral (DEVICE).
Who is sponsoring clinical trial NCT07167953?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07167953's enrollment target sits among peer trials
131 732nd of 2000 higher than 1,268 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia